AIM
FBIO icon

Axiom Investment Management’s Fortress Biotech FBIO Stock Holding History

Axiom Investment Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18
Closed – – 206
2022
Q3 		$0 Buy
+18
New +$270 ﹤0.01% 425
2021
Q2 		– Sell
-31
Closed -$2K – 174
2021
Q1 		$2K Buy
+31
New +$1.75K ﹤0.01% 192

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axiom Investment Management's FBIO Position: Q4 2022 in Review

Axiom Investment Management sold out of Fortress Biotech (FBIO) in Q4 2022, closing a stake of 18 shares.

Axiom Investment Management first reported a position in FBIO in Q1 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 49 funds tracked by Wall St. Rank hold FBIO as of Q4 2022.

  • Axiom Investment Management reported no remaining Fortress Biotech position as of Q4 2022 after selling out during the quarter.
  • Axiom Investment Management sold 18 Fortress Biotech shares in Q4 2022.
  • Axiom Investment Management first reported a position in Fortress Biotech in Q1 2021 and held it in 2 quarters.
  • Axiom Investment Management's Fortress Biotech position peaked at $2K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.